Literature DB >> 25538323

Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.

Natalia Rudovich1, Olga Pivovarova2, Özlem Gögebakan2, Andrea Sparwasser3, Wolfram Doehner4, Stefan D Anker5, Ayman M Arafat6, Andreas Bergmann7, Michael A Nauck8, Andreas F H Pfeiffer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25538323     DOI： 10.2337/dc14-1452

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.

Authors:  Natasha C Bergmann; Asger Lund; Lærke S Gasbjerg; Emma C E Meessen; Maria M Andersen; Sigrid Bergmann; Bolette Hartmann; Jens J Holst; Lene Jessen; Mikkel B Christensen; Tina Vilsbøll; Filip K Knop
Journal:  Diabetologia       Date:  2019-01-25       Impact factor: 10.122

2.  Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure.

Authors:  David Nathanson; Mats Frick; Bengt Ullman; Thomas Nyström
Journal:  Diabetol Metab Syndr       Date:  2016-01-12       Impact factor: 3.320

Review 3.  Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.

Authors:  Jordan Rowlands; Julian Heng; Philip Newsholme; Rodrigo Carlessi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.